A case report of tumor necrosis factor-alpha antibody-induced thrombocytopenia associated with emerging IgM anticardiolipin antibody in patients with scleroderma overlap/rheumatoid arthritis-Reference-Cited by-同舟云学术

A case report of tumor necrosis factor-alpha antibody-induced thrombocytopenia associated with emerging IgM anticardiolipin antibody in patients with scleroderma overlap/rheumatoid arthritis

Published:2006-07-06 Issue:6 Volume:26 Page:988-990
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Hamaguchi Masahide,Kawahito Yutaka,Ishino Hidetaka,Yoshida Makie,Yoshikawa Toshikazu

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-006-0229-y.pdf

Reference9 articles.

1. Elliott MJ, Maini RN, Feldmann M et al (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344(8930):1105–1110

2. Feldmann M, Maini RN (2002) Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies. Jt Bone Spine: Rev Rhum 69(1):12–18

3. Reimold AM (2002) TNFalpha as therapeutic target: new drugs, more applications. Curr Drug Targets Inflamm Allergy 1(4):377–392

4. Fleischmann R, Yocum D (2004) Does safety make a difference in selecting the right TNF antagonist? Arthritis Res Ther 6(Suppl 2):S12–S18

5. Moreland LW (2004) Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritis. Pharmacoeconomics 22(Supple 2):39–53

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic sclerosis and rheumatoid arthritis overlap syndrome – management of severe cardiac, pulmonary and articular involvement;Rheumatology;2023-03-08

2. Case Report: Severe thrombocytopenia induced by adalimumab in rheumatoid arthritis: A case report and literature review;Frontiers in Pharmacology;2022-10-25

3. Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence;Annals of Hematology;2022-06-27

4. Current Perspectives on the Role of TNF in Hematopoiesis Using Mice With Humanization of TNF/LT System;Frontiers in Immunology;2021-05-13

5. Tailoring biologic therapy for real-world rheumatoid arthritis patients;Expert Opinion on Biological Therapy;2020-11-15